Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.6.0 has been added, and the recruitment note 'No longer looking for participants' has been added to the record. The previous revision v3.5.5 has been removed.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page now shows Revision: v3.5.5 instead of v3.5.4, reflecting a new site release. This change updates the page metadata without altering study content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page history shows the revision tag updated from v3.5.3 to v3.5.4, indicating a platform release rather than a change to the study data.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing the previous v3.5.2. This indicates the study history record has been updated to a newer version.SummaryDifference0.0%

- Check60 days agoChange DetectedFooter Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.